CAP President Emily E. Volk, MD, FCAP, speaks with CNN on the monkeypox vaccine strategy shift. "It's a little too early to tell how it's going to help with the supply meeting demand, but I think logically, you use less vaccine for one person," explains Dr. Volk. "This is a dose-sparing approach, so it's going to allow for the doses that we do have to be usable for many more people. So, to me that is very positive and I am actually heartened that the public health community is thinking outside the box."
For the full article click here: Monkeypox vaccine strategy shift yields more supply for some, hurdles for others | CNN health